Trial Profile
A Study of Simbrinza Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2015
Price :
$35
*
At a glance
- Drugs Brimonidine/brinzolamide (Primary)
- Indications Open-angle glaucoma
- Focus Adverse reactions
- Sponsors Allergan
- 22 Jul 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 30 Jan 2015 New trial record